勘误：去泛素化酶UCHL1通过促进游离脂肪酸合成诱导HER2阳性乳腺癌对多柔比星产生耐药性。
Erratum: The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.
出版信息
Front Oncol. 2021 Apr 14;11:687249. doi: 10.3389/fonc.2021.687249. eCollection 2021.
Abstract
[This corrects the article DOI: 10.3389/fonc.2021.629640.].
摘要
[本文更正了文章的数字对象标识符：10.3389/fonc.2021.629640。]
相似文献
1
Erratum: The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.勘误：去泛素化酶UCHL1通过促进游离脂肪酸合成诱导HER2阳性乳腺癌对多柔比星产生耐药性。
Front Oncol. 2021 Apr 14;11:687249. doi: 10.3389/fonc.2021.687249. eCollection 2021.
2
The Deubiquitinating Enzyme UCHL1 Induces Resistance to Doxorubicin in HER2+ Breast Cancer by Promoting Free Fatty Acid Synthesis.去泛素化酶UCHL1通过促进游离脂肪酸合成诱导HER2+乳腺癌对阿霉素产生抗性。
Front Oncol. 2021 Feb 24;11:629640. doi: 10.3389/fonc.2021.629640. eCollection 2021.
3
Erratum: ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer.勘误：ANKRD44基因沉默：在人表皮生长因子受体2（Her2）样乳腺癌曲妥珠单抗耐药中的潜在作用。
Front Oncol. 2019 Jul 18;9:709. doi: 10.3389/fonc.2019.00709. eCollection 2019.
4
Erratum: Risk factors of brain metastasis and prognosis in HER2-positive breast cancer: A single-institution retrospective analysis from China.勘误：HER2阳性乳腺癌脑转移的危险因素及预后：一项来自中国的单机构回顾性分析。
Front Oncol. 2022 Sep 20;12:1027199. doi: 10.3389/fonc.2022.1027199. eCollection 2022.
5
Corrigendum: Effectiveness and Safety of Pyrotinib, and Association of Biomarker With Progression-Free Survival in Patients With HER2-Positive Metastatic Breast Cancer: A Real-World, Multicentre Analysis.勘误：吡咯替尼治疗HER2阳性转移性乳腺癌患者的有效性、安全性及生物标志物与无进展生存期的关系：一项真实世界、多中心分析
Front Oncol. 2021 Mar 5;11:661128. doi: 10.3389/fonc.2021.661128. eCollection 2021.
6
Corrigendum: STAT5a Confers Doxorubicin Resistance to Breast Cancer by Regulating ABCB1.勘误：STAT5a通过调控ABCB1赋予乳腺癌多柔比星耐药性。
Front Oncol. 2022 Mar 9;12:880458. doi: 10.3389/fonc.2022.880458. eCollection 2022.
7
Corrigendum: Emodin Interferes With AKT1-Mediated DNA Damage and Decreases Resistance of Breast Cancer Cells to Doxorubicin.勘误：大黄素干扰AKT1介导的DNA损伤并降低乳腺癌细胞对多柔比星的耐药性。
Front Oncol. 2021 Jun 2;11:687841. doi: 10.3389/fonc.2021.687841. eCollection 2021.
8
Differential expression of ubiquitin carboxy-terminal hydrolase L1 in breast carcinoma and its biological significance.乳腺癌中泛素羧基末端水解酶 L1 的差异表达及其生物学意义。
Hum Pathol. 2013 Sep;44(9):1838-48. doi: 10.1016/j.humpath.2013.02.006. Epub 2013 May 7.
9
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies.勘误：乳腺癌中的化学抗性与转移——分子机制及新型临床策略
Front Oncol. 2021 Aug 17;11:745052. doi: 10.3389/fonc.2021.745052. eCollection 2021.
10
Corrigendum: PAM50 Subtypes in Baseline and Residual Tumors Following Neoadjuvant Trastuzumab-Based Chemotherapy in HER2-Positive Breast Cancer: A Consecutive-Series From a Single Institution.勘误：HER2阳性乳腺癌新辅助曲妥珠单抗化疗后基线和残留肿瘤中的PAM50亚型：来自单一机构的连续系列研究。
Front Oncol. 2019 Sep 25;9:967. doi: 10.3389/fonc.2019.00967. eCollection 2019.
Zotero 插件